Mike Anderson Email

President / Chief Administrative Officer . AVM Biotechnology

Current Roles

Employees:
18
Revenue:
$1.4M
About
AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 triggers the production and release of endogenous gamma delta+ Natural Killer T cells and could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology. The company is committed to developing products that improve outcomes without additional suffering because side effects from treatments should never be worse than the diseases themselves.
AVM Biotechnology Address
1749 Dexter Ave N
Seattle, WA
United States
AVM Biotechnology Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.